STRATA Skin Sciences, Inc. Share Price BOERSE MUENCHEN

Equities

E2O

US86272A3059

Advanced Medical Equipment & Technology

Market Closed - BOERSE MUENCHEN 14:13:33 17/06/2024 BST 5-day change 1st Jan Change
2.8 EUR -17.65% Intraday chart for STRATA Skin Sciences, Inc. 0.00% 0.00%

Financials

Sales 2024 * 31.16M 29.09M 2.46B Sales 2025 * 33.82M 31.57M 2.68B Capitalization 10.76M 10.05M 851M
Net income 2024 * -10M -9.34M -791M Net income 2025 * -5M -4.67M -395M EV / Sales 2024 * 0.35 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.32 x
P/E ratio 2024 *
-1.1 x
P/E ratio 2025 *
-1.98 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 59.41%
More Fundamentals * Assessed data
Dynamic Chart
Current month-23.08%
1 month-21.79%
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 09/04/18
Director of Finance/CFO 42 05/07/21
Chief Operating Officer - 31/12/14
Members of the board TitleAgeSince
Chairman 56 28/05/18
Chief Executive Officer 60 09/04/18
Director/Board Member 60 28/05/18
More insiders
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
3.07 USD
Average target price
26 USD
Spread / Average Target
+746.91%
Consensus